Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Alector $240 million stock offering

Davis Polk advised the underwriters in connection with Alector, Inc.’s $240 million public offering of 9,602,500 shares of common stock, which includes the 1,252,500 shares offered pursuant…

Ardelyx, Inc. $144 Million Follow-On Public Offering

Davis Polk advised the joint book-running managers for the public offering of common stock by Ardelyx, Inc for gross proceeds of approximately $144 million, including the full exercise…

Natera, Inc. $230 Million Follow-On Public Offering

Davis Polk advised the several underwriters in connection with the follow-on offering of 6,571,428 shares of common stock of Natera, Inc. for total gross proceeds of approximately $230…

Allakos Inc. $402 Million Follow-On Public Offering

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the follow-on offering of 5,227,272 shares of common stock of Allakos Inc. for…

Seattle Genetics, Inc. $575 Million Equity Offering

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering of common stock by Seattle Genetics, Inc. for gross…

NeoGenomics Common Stock Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the follow-on offering of 8,050,000 shares of common stock of…

Natera, Inc. $100 Million Follow-On Public Offering

Davis Polk advised the several underwriters in connection with the follow-on offering of 5,263,158 shares of common stock of Natera, Inc. for total gross proceeds of approximately $100…

Alector, Inc. Initial Public Offering

Davis Polk advised the underwriters in connection with an initial public offering of 9,250,000 shares of common stock of Alector, Inc. at $19.00 per share, for total gross proceeds of $175…

Secondary Offering of NeoGenomics, Inc. Common Stock

Davis Polk advised the sole book-runner in connection with the SEC-registered secondary offering of 10,835,145 shares of common stock of NeoGenomics, Inc. by the selling stockholder, GE…
Back to top